August 23, 2024 10:29 AM EDTUpdated 10:43 AM
News Briefing

Novo's in­no­va­tion hub ex­pands to Bay Area; SIGA's new Tpoxx or­der

Kyle LaHucik

Senior Reporter

No­vo Nordisk’s Bio In­no­va­tion Hub goes west: The Dan­ish phar­ma’s ear­ly-stage R&D unit is part­ner­ing with MBC Bi­o­Labs, an in­cu­ba­tor in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Af­ter stock slides, Am­gen ad­dress­es bone den­si­ty talk on obe­si­ty drug

Trump picks vac­cine skep­tic Kennedy to lead HHS, in what would be an up­heaval of US health pol­i­cy

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times